
Keywords: ASPE; allele-specific primer extension; CI; confidence interval; DST; drug susceptibility testing; FQs; fluoroquinolones; INH; isoniazid; L-J; Lowenstein-Jensen; LVX; levofloxacin; MDR-TB; multidrug-resistant tuberculosis; MXF; moxifloxacin; OFX; oflo